EMA and the national competent authorities are reminding patients with confirmed or suspected coronavirus disease (COVID-19) to report suspected side effects that they experience with any of the medicines they are taking.
This includes medicines to treat COVID-19, as well as medicines taken by patients to manage long-term, pre-existing conditions. It also includes medicines that patients might be using off-label to treat COVID-19.
Patients are reminded that there are currently no medicines authorised to treat COVID-19. However, in the context of the pandemic, several treatments authorised for other diseases are being used in patients with COVID-19.
Patient reporting complements the information received from healthcare professionals who have continued to report suspected patient side effects with medicines taken during the pandemic.
For more information:
Reporting suspected side effects of medicines in patients with COVID-19
